How Genocea Biosciences Inc (GNCA) Stacks Up Against Its Peers

Since Genocea Biosciences Inc (NASDAQ:GNCA) has experienced falling interest from the aggregate hedge fund industry, it’s easy to see that there exists a select few funds who were dropping their full holdings in the third quarter. Interestingly, Ben Levine, Andrew Manuel and Stefan Renold’s LMR Partners cashed in the biggest position of the 700 funds studied by Insider Monkey, worth about $0.1 million in stock. Joseph Edelman’s fund, Perceptive Advisors, also sold off its stock, about $0.1 million worth.

Let’s go over hedge fund activity in other stocks similar to Genocea Biosciences Inc (NASDAQ:GNCA). These stocks are Genie Energy Ltd (NYSE:GNE), Willdan Group, Inc. (NASDAQ:WLDN), Fortress Biotech Inc (NASDAQ:FBIO), and Hardinge Inc. (NASDAQ:HDNG). This group of stocks’ market valuations are similar to GNCA’s market valuation.

As you can see these stocks had an average of 4 hedge funds with bullish positions and the average amount invested in these stocks was $10 million. That figure was $8 million in GNCA’s case. Genie Energy Ltd (NYSE:GNE) is the most popular stock in this table. On the other hand Fortress Biotech Inc (NASDAQ:FBIO) is the least popular one with only 2 bullish hedge fund positions. Compared to these stocks Genocea Biosciences Inc (NASDAQ:GNCA) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None